While Ketamine was originally FDA approved for surgical anesthesia, today low-dose intravenous (IV) Ketamine is now frequently used “off-label” due to its positive effects on the various disorders including depression, suicidal ideation, Obsessive Compulsive Disorder (OCD), Post Traumatic Stress Disorder (PTSD), Postpartum Depression (PPD), and several pain syndromes.
Below is a selection of Ketamine studies across a range of mood disorder and pain conditions.
Depression and Ketamine:
Human Psychopharmacology: Clinical and Experimental
Annals of the New York Academy of Sciences (2015)
PTSD and Ketamine:
JAMA Psychiatry (2014)
Anxiety and Ketamine:
Pain and Ketamine:
European Journal of Pain(2017)
British Journal of Clinical Pharmacology (2014)
American Society of Anesthesiologists (2017)